Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2024-10-30
Clinical Trial Update: Dual-targeting HER2 and PD-L1 CAR-T for Solid Tumors [EARLY_Phase 1]
An early-phase (Phase 1) trial is evaluating a dual-targeting CAR-T therapy against HER2 and PD-L1 for solid tumors, including metastatic pe…